<DOC>
	<DOCNO>NCT00254553</DOCNO>
	<brief_summary>Hypogonadal male , particularly whose condition manifest later life , may experience common symptom associate hypogonadism . Questionnaires developed ass symptom need test . The primary purpose study test validate Patient-Reported Symptom Measure , Androgen Deficiency Quality Life Questionnaire Patient Global Impression Scale .</brief_summary>
	<brief_title>A Study Test Measure Symptoms Older Men With Low Testosterone On Off Testosterone Replacement Treatment ( P05815 )</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men lateonset hypogonadism either testosterone treatment naïve treatment : symptom androgen deficiency screening ( washout applicable ) i.e . positive score Androgen Deficiency Aging Male ( ADAM ) Questionnaire ( `` yes '' answer question 1 7 three question ) . morning total T level &lt; =3 ng/mL ( &lt; =300 ng/dL ; &lt; =10.4 nmol/l ) two separate day prior randomization ( appropriate washout , applicable ) . calculate free T &lt; =0.074 ng/mL . least 50 75 year age . BMI least 18 kg/m^2 32 kg/m^2 Inclusion Criteria Normogonadal Men : morning total T level &lt; =3 ng/mL ( &lt; =300 ng/dL ; &lt; =10.4 nmol/L ) . calculate free T &lt; =0.074 ng/mL . least 50 75 year age . BMI least 18 kg/m^2 32 kg/m^2 History current diagnosis prostate cancer clinically significant find prostate examination Severe obstructive symptom benign prostate hypertrophy Prostate specific antigen ( PSA ) level great 4 ng/mL screen History current diagnosis carcinoma breast Known chronic polycythemia and/or hematocrit great 50 % screen Treatmentnaïve subject hyperprolactinemia screen ( serum prolactin level &gt; =50 ng/mL ) Hematological biochemical value screen outside reference range consider clinically significant opinion investigator clinically significant abnormal physical finding prior randomization sensitive trial medication component History presence hepatic renal disorder consider clinically relevant opinion investigator . Exclusion Criteria Normogonadal Men : Presence previous diagnosis androgen deficiency . Previous present use testosterone preparation Use medication within 12 week prior visit may interfere objective trial : hypothalamic/pituitary hormone analogue ( e.g. , gonadotropin , ACTH , STH , GnRH agonists antagonist , etc . ) ; sex steroid Any disease opinion investigator might compromise confound subject 's symptomatology ( e.g. , presence clinically significant depression psychiatric disorder , unstable endocrine disorder , sleep apnea , cardiovascular cerebrovascular disease , etc . )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>